Data / Form D filings / CORMATRIX CARDIOVASCULAR INC
CORMATRIX CARDIOVASCULAR INC: Form D filings
CORMATRIX CARDIOVASCULAR INC, a biotechnology company in Roswell, GA, filed 6 Form D notices with the SEC between 2011 and 2018. The latest, on April 20, 2018, reports an offering of $8 million with nothing sold yet.
Find out what CORMATRIX CARDIOVASCULAR INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1100 Old Ellis Road, Roswell, GA, 30076
- Phone
- (678) 566-2628
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Georgia
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1434206
The full lists. Form D filings in Georgia: 1,337 rows, $66.85, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 20, 2018 | New notice | $8,000,000 | $0 | $8,000,000 | 0 | Yet to occur | sec.gov |
| Jan 16, 2015 | Amendment | $25,000,000 | $1,000,000 | $24,000,000 | 2 | Oct 20, 2014 | sec.gov |
| Jan 17, 2014 | New notice | $25,000,000 | $250,000 | $24,750,000 | 1 | Jan 9, 2014 | sec.gov |
| Oct 15, 2013 | Amendment | $25,000,000 | $24,610,032 | $389,968 | 34 | Jul 5, 2011 | sec.gov |
| Jun 11, 2012 | Amendment | $25,000,000 | $15,360,015 | $9,639,985 | 23 | Jul 5, 2011 | sec.gov |
| Jun 16, 2011 | New notice | $25,000,000 | $0 | $25,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard M Ferrari | Director | |
| Edgar B Rey | Executive Officer, Director | |
| John Cornelius Thomas | Executive Officer | |
| Mark W Bleyer | Director | |
| Robert G Matheny | Executive Officer, Director, Promoter | |
| R Ruffner Page | Director |
Other biotechnology companies in Georgia that filed recently
- Opus Medical Therapies, LLC $485,089 · Sep 22, 2026
- Airway Therapeutics, Inc. $43.5 million · Sep 9, 2026
- FEMASYS INC $30 million · Aug 20, 2026
Every Form D from the week of Apr 16, 2018 · All recent filings in Georgia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CORMATRIX CARDIOVASCULAR INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.